Nour Al-Mozain/LinkedIn, Abdullah Alswied/LinkedIn
May 22, 2026, 17:20
Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
Nour Al-Mozain, Hemopathologist, Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn:
“A fresh start this morning hosting the author Abdullah Alswied of a highly impactful study on optimizing Peripheral Blood Stem Cell collection!
The core takeaway:
A single intra-apheresis CD34+ measurement, taken at or beyond 1.20 processed blood volumes, provides a reliable, real-time predictor of the final PBSC yield.
What is the real-world clinical impact of this approach?
- Enhanced Collection Efficiency: Streamlining the apheresis process using real-time data.
- Reduced Donor Burden: Minimizing unnecessary procedural time for donors.”
Other posts featuring Nour Al-Mozain on Hemostasis Today.
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients